Literature DB >> 24792740

Usefulness of electrocardiographic parameters for risk prediction in arrhythmogenic right ventricular dysplasia.

Ardan M Saguner1, Sabrina Ganahl1, Samuel H Baldinger2, Andrea Kraus3, Argelia Medeiros-Domingo4, Sebastian Nordbeck1, Arhan R Saguner1, Andreas S Mueller-Burri5, Laurent M Haegeli1, Thomas Wolber6, Jan Steffel1, Nazmi Krasniqi1, Etienne Delacrétaz2, Thomas F Lüscher6, Leonhard Held3, Corinna B Brunckhorst1, Firat Duru7.   

Abstract

The value of electrocardiographic findings predicting adverse outcome in patients with arrhythmogenic right ventricular dysplasia (ARVD) is not well known. We hypothesized that ventricular depolarization and repolarization abnormalities on the 12-lead surface electrocardiogram (ECG) predict adverse outcome in patients with ARVD. ECGs of 111 patients screened for the 2010 ARVD Task Force Criteria from 3 Swiss tertiary care centers were digitized and analyzed with a digital caliper by 2 independent observers blinded to the outcome. ECGs were compared in 2 patient groups: (1) patients with major adverse cardiovascular events (MACE: a composite of cardiac death, heart transplantation, survived sudden cardiac death, ventricular fibrillation, sustained ventricular tachycardia, or arrhythmic syncope) and (2) all remaining patients. A total of 51 patients (46%) experienced MACE during a follow-up period with median of 4.6 years (interquartile range 1.8 to 10.0). Kaplan-Meier analysis revealed reduced times to MACE for patients with repolarization abnormalities according to Task Force Criteria (p = 0.009), a precordial QRS amplitude ratio (∑QRS mV V1 to V3/∑QRS mV V1 to V6) of ≤ 0.48 (p = 0.019), and QRS fragmentation (p = 0.045). In multivariable Cox regression, a precordial QRS amplitude ratio of ≤ 0.48 (hazard ratio [HR] 2.92, 95% confidence interval [CI] 1.39 to 6.15, p = 0.005), inferior leads T-wave inversions (HR 2.44, 95% CI 1.15 to 5.18, p = 0.020), and QRS fragmentation (HR 2.65, 95% CI 1.1 to 6.34, p = 0.029) remained as independent predictors of MACE. In conclusion, in this multicenter, observational, long-term study, electrocardiographic findings were useful for risk stratification in patients with ARVD, with repolarization criteria, inferior leads TWI, a precordial QRS amplitude ratio of ≤ 0.48, and QRS fragmentation constituting valuable variables to predict adverse outcome.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24792740     DOI: 10.1016/j.amjcard.2014.02.031

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

1.  Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.

Authors:  Kang Yin; Ligang Ding; Yuqiu Li; Wei Hua
Journal:  Clin Cardiol       Date:  2017-01-31       Impact factor: 2.882

2.  Patients with Obstructive Sleep Apnea Have Cardiac Repolarization Disturbances when Travelling to Altitude: Randomized, Placebo-Controlled Trial of Acetazolamide.

Authors:  Tsogyal Daniela Latshang; Barbara Kaufmann; Yvonne Nussbaumer-Ochsner; Silvia Ulrich; Michael Furian; Malcolm Kohler; Robert Thurnheer; Ardan Muammer Saguner; Firat Duru; Konrad Ernst Bloch
Journal:  Sleep       Date:  2016-09-01       Impact factor: 5.849

3.  Running the Risk: Exercise and Arrhythmogenic Cardiomyopathy.

Authors:  Lauren Eberly; Lohit Garg; Mahesh Vidula; Nosheen Reza; Sheela Krishnan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2021-09-18

4.  Arrhythmogenic Cardiomyopathy: Electrical and Structural Phenotypes.

Authors:  Deniz Akdis; Corinna Brunckhorst; Firat Duru; Ardan M Saguner
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-08

Review 5.  Arrhythmogenic Right Ventricular Cardiomyopathy: Risk Stratification and Indications for Defibrillator Therapy.

Authors:  Alessandro Zorzi; Ilaria Rigato; Barbara Bauce; Kalliopi Pilichou; Cristina Basso; Gaetano Thiene; Sabino Iliceto; Domenico Corrado
Journal:  Curr Cardiol Rep       Date:  2016-06       Impact factor: 2.931

Review 6.  Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.

Authors:  Hugh Calkins; Domenico Corrado; Frank Marcus
Journal:  Circulation       Date:  2017-11-21       Impact factor: 29.690

7.  Electrocardiographic features of disease progression in arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Ardan M Saguner; Sabrina Ganahl; Andrea Kraus; Samuel H Baldinger; Deniz Akdis; Arhan R Saguner; Thomas Wolber; Laurent M Haegeli; Jan Steffel; Nazmi Krasniqi; Thomas F Lüscher; Felix C Tanner; Corinna Brunckhorst; Firat Duru
Journal:  BMC Cardiovasc Disord       Date:  2015-01-19       Impact factor: 2.298

Review 8.  Ventricular arrhythmias in arrhythmogenic right ventricular dysplasia.

Authors:  Johnson Francis; Narayanan Namboodiri
Journal:  Indian Pacing Electrophysiol J       Date:  2015-04-01

9.  Precordial T-Wave Inversions in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy Who Present with the Initial Features of Right Ventricular Outflow Tract Arrhythmia.

Authors:  Fa-Po Chung; Cheng-I Wu; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Chin-Yu Lin; Ting-Yung Chang; Tze-Fan Chao; Jo-Nan Liao; Ta-Chuan Tuan; Ling Kuo; Chih-Min Liu; Chye-Gen Chin; Ying-Chieh Liao; Shih-Ann Chen
Journal:  Acta Cardiol Sin       Date:  2020-09       Impact factor: 2.672

10.  Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement.

Authors:  Domenico Corrado; Thomas Wichter; Mark S Link; Richard N W Hauer; Frank E Marchlinski; Aris Anastasakis; Barbara Bauce; Cristina Basso; Corinna Brunckhorst; Adalena Tsatsopoulou; Harikrishna Tandri; Matthias Paul; Christian Schmied; Antonio Pelliccia; Firat Duru; Nikos Protonotarios; Na Mark Estes; William J McKenna; Gaetano Thiene; Frank I Marcus; Hugh Calkins
Journal:  Circulation       Date:  2015-07-27       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.